Cortechs.ai | Performance Evaluation for Multiple Sclerosis Identification Models Based on MRI  Imaging and Machine Learning

Performance Evaluation for Multiple Sclerosis Identification Models Based on MRI Imaging and Machine Learning

Cortechs.ai’ abstract titled “Determining Brain Age Using Machine Learning Combined With Automated Brain Segmentation and PET imaging In Normal, Alzheimer’s Disease and Mild Cognitive Impairment Subjects” was accepted by ACTRIMS

Lead author and Cortechs.ai Principal Scientist, Weidong Luo, presented our findings at the 2020 ACTRIMS meeting on Friday, February 28th.

Findings

BACKGROUND
Accurate and early diagnosis of Multiple Sclerosis (MS) is critical for patients to start treatments. In MS
patients, there is a high correlation between various atrophy and physical and cognitive impairments. With the recent
advances in image processing and machine learning methods, a better identification of MS patients using magnetic
resonance imaging (MRI) became achievable.
OBJECTIVE
To evaluate the performance of machine learning models for identifying MS subjects and to study feature
importance selected by models.
METHODS
463 MS (102m/361f, age:18-71yo) and 2315 normal subjects’ data (1080m/1235f, age:18-71yo) were used
in this study. T1-weighted MRI scans were processed by NeuroQuant 3.0 (Cortechs.ai Inc, San Diego, USA) to
generate brain volumetric information (including the volume of cerebral white matter (WM) hypo-intensities). Random
Forests algorithm was used for creating machine learning models. Brain structure volume normalized by Intracranial
Volume (ICV) were used as the input. One-third randomly selected data were used for testing while rest for training.
The performance of the models and the importance of the features based on the whole age range data and specific
age range data were evaluated.
RESULTS
For model one (all data), model area under the curve (AUC) is 0.95 and the precision is 93% and 98%;
sensitivity is 100% and 63% for normal and MS subjects respectively. Top five features are cerebral WM Hypo-
intensities, Thalamus and Cerebellar WM, Age and Isthmus Cingulate. For model two (age < 40 years), the model
AUC is 0.94 and the precision is 92% and 92% for normal and MS subjects while sensitivity is 98% and 76% for
normal and MS subjects respectively. Top three features are the same as the model one. Next two features are
cerebral WM and posterior Superior Temporal Sulcus. For model three (age >= 40 years), the AUC is 0.94 and the
precision is 94% and 96%, sensitivity is 100% and 57% for normal and MS subjects respectively. Top five features
Thalamus, Age, Cerebellar WM, Cerebral WM Hypo-intensities, Isthmus Cingulate.
CONCLUSION
Machine learning models showed high classification performance between normal and MS.
Furthermore, models constructed with data from different age ranges selected different key features thus enabled different precision and sensitivity performance for MS classification. This also suggests evolving effects of disease upon brain during progression. These models might be used as MS classifiers to assist clinicians in decision making.

 

Cortechs.ai | Performance Evaluation for Multiple Sclerosis Identification Models Based on MRI  Imaging and Machine Learning

More Resources

12/18/2025

Reimbursement Essentials for Quantitative Imaging: Key Takeaways From Our Expert Webinar

Our reimbursement webinar walked through best practices for billing, coding, and securing payment for NeuroQuant and OnQ Prostate, helping inform providers.

12/10/2025

Reflections on RSNA 2025 and What We Learned at the Cortechs.ai Booth 

If there was one overall takeaway from RSNA 2025, it’s that clinicians are ready for tools that reduce manual work and make reporting more consistent.

12/09/2025

Dementia Imaging: Case-based PET/MRI Approach

Join us for a webinar that will unlock the latest insights in dementia imaging with Dr. Ana M. Franceschi, MD PhD.

12/09/2025

SNO 2025 Recap: Collaboration Driving Innovation in Neuro-Oncology

The 2025 Society for Neuro-Oncology meeting was more than a conference, it was a hub of collaboration and conversation among industry leaders and physicians.

11/19/2025

Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology

The companies will integrate Cortechs.ai’s advanced AI-enabled neuroimaging analytics directly into Philips’ MR systems.

11/17/2025

Unlocking the Value of NeuroQuant Reports: Different Use Cases Across Clinical Practice

From neurodegeneration and demyelination to development, trauma, and seizures, NeuroQuant supports better decision‑making, communication, and patient care
Scroll to Top